Voytek R. Slowik, MD
Title | Medical Director, Pediatric Non-Alcoholic Fatty Liver Disease-Multidisciplinary Clinic |
---|
Institution | Children's Mercy Kansas City |
---|
Department | Pediatrics |
---|
Address | 2401 Gillham Rd Kansas City MO 64108
|
---|
ORCID
.gif) | 0000-0003-0081-3928  |
---|
vCard | Download vCard |
---|
|
|
|
Title | Associate Program Director, Pediatric Gastroenterology |
---|
Institution | Children's Mercy Kansas City |
---|
Department | Pediatrics |
---|
|
---|
Title | Pediatric Transplant Hepatologist |
---|
Institution | Children's Mercy Kansas City |
---|
Department | Pediatrics |
---|
|
---|
Title | Clinical Assistant Professor of Pediatrics |
---|
Institution | University of Missouri-Kansas City |
---|
Department | Pediatrics |
---|
|
---|
|
Biography University Of Kansas, Kansas City, KS | MD | 2011 | | Children's Mercy Hospital, Kansas City, MO | Residency | 2014 | | Children's Mercy Hospital, Kansas City, MO | Fellowship | 2017 | Pediatric Gastroenterology | Seattle Children's Hospital, Seattle, WA | Fellowship | 2018 | Pediatric Transplant Hepatology |
Overview Research Voytek Slowik, MD, graduated with a Bachelor of Science degree in cellular biology cum laude from the University of Kansas. He then went on to graduate from medical school at the University of Kansas School of Medicine. He first joined the team at Children’s Mercy – Kansas City as a general pediatric resident in 2011 and stayed until completion of his pediatric gastroenterology fellowship in 2017. Dr. Slowik then completed a fellowship in pediatric transplant hepatology at Seattle Children’s Hospital in 2018 and then came back to Children’s Mercy – Kansas City as faculty. As a junior career physician scientist, he has been focusing his research into portal hypertension, transplant rejection, and pediatric non-alcoholic fatty liver disease. Active collaborations with the Society of Pediatric Liver Transplantation (SPLIT), Center for Children’s Healthy Lifestyle’s & Nutrition (CHLN), and the Department of Pharmacology, Toxicology & Therapeutics at the University of Kansas School of Medicine have resulted in multiple grant awards and publications. His true pride remains the family he builds with his wife, Kaitlin, and their four children in Kansas City.
Bibliography
-
Slowik V, Wasserkrug H, Fischer RT, Connelly M, Deacy A, Hampl S, Daniel J. Readiness to change and prospective effects of weight management programs in pediatric nonalcoholic fatty liver disease. Clin Transl Sci. 2020 Nov 03. PMID: 33142354.
-
Slowik V, Lerret SM, Lobritto SJ, Voulgarelis S, Vitola BE. Variation in immunosuppression practices among pediatric liver transplant centers-Society of Pediatric Liver Transplantation survey results. Pediatr Transplant. 2020 Oct 07; e13873. PMID: 33026158.
-
Slowik V, Hildreth A, Pacheco MC, Finn LS, King J, Shivaram G, Files M, Hsu EK, Horslen S. Hepatopulmonary Syndrome in an Adolescent With Insidious Hypoxia and Small Intrahepatic Portal Venous Shunts: Posttransplant Benefit From Sildenafil. Pediatr Dev Pathol. 2020 Aug 19; 1093526620945951. PMID: 32813578.
-
Fischer RT, Day JC, Wasserkrug H, Faseler M, Kats A, Daniel JF, Slowik V, Andrews W, Hendrickson RJ. Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary disease. Pediatr Transplant. 2020 Aug 10; e13807. PMID: 32777150.
-
Slowik V, Monroe EJ, Friedman SD, Hsu EK, Horslen S. Pressure gradients, laboratory changes, and outcomes with transjugular intrahepatic portosystemic shunts in pediatric portal hypertension. Pediatr Transplant. 2019 05; 23(3):e13387. PMID: 30932316.
-
Slowik V, Borude P, Jaeschke H, Woolbright BL, Lee WM, Apte U. Leukocyte cell derived chemotaxin-2 (Lect2) as a predictor of survival in adult acute liver failure. Transl Gastroenterol Hepatol. 2019; 4:17. PMID: 30976720.
-
Slowik V, Apte U. Leukocyte Cell-Derived Chemotaxin-2: It's Role in Pathophysiology and Future in Clinical Medicine. Clin Transl Sci. 2017 07; 10(4):249-259. PMID: 28466965.
-
Slowik V, Fischer R. The NASPGHAN Fellows Concise Review of Pediatric Gastroenterology, Hepatology and Nutrition. Vascular Diseases of the Liver. 2017.
-
Slowik V, Attard T, Dai H, Shah R, Septer S. Desmoid tumors complicating Familial Adenomatous Polyposis: a meta-analysis mutation spectrum of affected individuals. BMC Gastroenterol. 2015 Jul 16; 15:84. PMID: 26179480.
-
Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, Lyons JJ, Engelhardt KR, Zhang Y, Topcagic N, Roberson ED, Matthews H, Verbsky JW, Dasu T, Vargas-Hernandez A, Varghese N, McClain KL, Karam LB, Nahmod K, Makedonas G, Mace EM, Sorte HS, Perminow G, Rao VK, O'Connell MP, Price S, Su HC, Butrick M, McElwee J, Hughes JD, Willet J, Swan D, Xu Y, Santibanez-Koref M, Slowik V, Dinwiddie DL, Ciaccio CE, Saunders CJ, Septer S, Kingsmore SF, White AJ, Cant AJ, Hambleton S, Cooper MA. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015 Jan 22; 125(4):591-9. PMID: 25359994.
-
Slowik, V, Dinwiddie DL, Ciaccio CE, Shao Lei, Saunders CJ, Vanderhoof JA, Kingsmore SF, Septer S. . Journal of Genomes and Exomes. A Novel Varient in the Stat 3 Gene Associated with Autoimmune Enteropathy in a Father-Son Duo. 2014; 3:1-5.
-
Septer S, Slowik V, Morgan R, Dai H, Attard T. Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals. Hered Cancer Clin Pract. 2013 Oct 05; 11(1):13. PMID: 24093640.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2013 | 1 | 2014 | 2 | 2015 | 1 | 2017 | 2 | 2019 | 2 | 2020 | 4 |
To return to the timeline, click here.
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|